United Kingdom
“The quality and depth of innovation that emerges from the UK life sciences industry …. is the reason why UK Prix Galien exists – to honor excellence in medical R&D and celebrate the achievements of all those on whom we rely for the discovery and development of new innovation.”
— Sir Michael Rawlins, Chairman, Medicines and Healthcare Products Regulatory Agency
Committee
